The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling.

Area of Science:

• Pulmonary biology and disease research.
• Cellular and molecular characterization of lung tissue.

Background:

• Understanding lung physiology requires knowledge of its diverse cell types.
• Identifying cell-specific molecular markers is crucial for advancing lung biology and disease research.

Purpose of the Study:

• To identify genes with elevated expression in the lung and localize their protein products to specific cell types.
• To explore the potential of lung-specific genes as biomarkers in non-small-cell lung cancer (NSCLC).

Main Methods:

• Genome-wide RNA sequencing of normal lung parenchyma and 26 other tissue types.
• Antibody-based protein profiling to determine cell-specific expression.
• Survival analysis of pneumocyte-specific genes using transcriptomics data from 7 NSCLC cohorts.

Main Results:

• 221 genes showed significantly higher expression in the lung compared to other tissues.
• Identified known and novel lung-associated proteins.
• Ten genes (SFTPB, SFTPC, SFTPD, SLC34A2, LAMP3, CACNA2D2, AGER, EMP2, NKX2-1, NAPSA) were associated with survival in lung adenocarcinoma patients.

Conclusions:

• An integrated omics approach successfully identified lung-specific genes and their cellular localization.
• The identified genes represent promising biomarker candidates for non-small-cell lung cancer.
• These findings offer potential starting points for further research in lung health and disease.